VVA
Vida Ventures Advisors Portfolio holdings
AUM
$15.9M
This Quarter Return
-12.11%
1 Year Return
+52.49%
3 Year Return
+45.65%
5 Year Return
-49.37%
10 Year Return
–
AUM
$396M
AUM Growth
+$396M
(-19%)
Cap. Flow
+$11.2K
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
|
$11.2K |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Praxis Precision Medicines
PRAX
$958M
| $96.3M | 24.33% |
2,939,329
| – | – |
|
|
KNTE
2
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $85.6M | 21.63% |
2,747,433
+359
| +0% | +$11.2K |
|
|
KRON
3
DELISTED
Kronos Bio
KRON
| $80.9M | 20.45% |
2,765,314
| – | – |
|
4
Allogene Therapeutics
ALLO
$251M
| $63.5M | 16.04% |
1,798,163
| – | – |
|
5
Dyne Therapeutics
DYN
$1.92B
| $46M | 11.61% |
2,960,046
| – | – |
|
|
OYST
6
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $14.2M | 3.59% |
778,468
| – | – |
|
7
Q32 Bio
QTTB
$20.9M
| $7.25M | 1.83% |
770,845
| – | – |
|
8
Assembly Biosciences
ASMB
$190M
| $2.07M | 0.52% |
450,000
| – | – |
|